SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,274,176 | +11.9% | 86,138 | +1.5% | 0.02% | +21.1% |
| Q2 2023 | $16,333,318 | -91.0% | 84,865 | -90.5% | 0.02% | -91.2% |
| Q1 2023 | $181,475,820 | +47.7% | 896,308 | -6.2% | 0.22% | +49.0% |
| Q4 2022 | $122,839,128 | -3.3% | 955,875 | +2.9% | 0.14% | -7.1% |
| Q3 2022 | $127,055,000 | -25.9% | 928,560 | -4.2% | 0.16% | -19.2% |
| Q2 2022 | $171,500,000 | +5.2% | 969,259 | -14.3% | 0.19% | +55.6% |
| Q1 2022 | $162,975,000 | -7.5% | 1,131,386 | -0.7% | 0.12% | -15.6% |
| Q4 2021 | $176,201,000 | -8.4% | 1,139,724 | +0.6% | 0.15% | -10.4% |
| Q3 2021 | $192,344,000 | +12.9% | 1,132,775 | +4.9% | 0.16% | +17.1% |
| Q2 2021 | $170,432,000 | +1391.1% | 1,079,503 | +1211.5% | 0.14% | +775.0% |
| Q1 2021 | $11,430,000 | -32.9% | 82,312 | -15.4% | 0.02% | -36.0% |
| Q4 2020 | $17,036,000 | – | 97,272 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |